Halozyme Therapeutics, Inc.
2020 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 1,981 | 0.0% | 29,428 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 2,202 | 0.0% | 30,019 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 1,647 | 0.0% | 31,659 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 1,941 | 0.0% | 30,412 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 1,343 | 0.0% | 28,099 | 12/31/2024 |
| 2024 Q3 | 11/7/2024 | 1,598 | 0.0% | 27,924 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 1,477 | 0.0% | 28,209 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 1,189 | 0.0% | 29,221 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 1,077 | 0.0% | 29,149 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 1,020 | 0.0% | 26,714 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 2,296 | 0.0% | 63,653 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 2,326 | 0.0% | 60,900 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 3,461 | 0.0% | 60,827 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 2,160 | 0.0% | 54,627 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 2,403 | 0.0% | 54,612 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 2,058 | 0.0% | 51,597 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 1,877 | 0.0% | 46,677 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 1,913 | 0.0% | 47,024 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 2,025 | 0.0% | 44,588 | 6/30/2021 |
| 2021 Q1 | 5/12/2021 | 1,769 | 0.0% | 42,421 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 1,812 | 0.0% | 42,434 | 12/31/2020 |